Genetic Arg-304-His substitution in GRK5 protects against sepsis progression by alleviating NF-κB-mediated

Mingwei Xu1, Yiming Shao2, Kaisheng Lin1

  • 1Jieyang Medical Research Center, Jieyang People's Hospital, Jieyang Affiliated Hospital of Sun Yat-sen University, Jieyang, Guangdong, PR China.

Abstract

Insights

Genetic variants in GRK5 influence sepsis outcomes. The rs2230349 G-to-A mutation in GRK5 may offer protection against sepsis progression and mortality by reducing inflammatory responses. This finding could lead to personalized sepsis treatments.

Area of Science:

  • Genetics
  • Immunology
  • Sepsis Pathogenesis

Background:

  • G protein-coupled receptor kinase 5 (GRK5) plays a key role in regulating inflammation during sepsis.
  • Previous research highlights GRK5's involvement in sepsis-related inflammatory processes.

Purpose of the Study:

  • To investigate the clinical association between GRK5 genetic variants and sepsis.
  • To explore the mechanisms by which these variants regulate sepsis-induced inflammation and pathogenesis.

Main Methods:

  • A case-control study involving 1081 septic patients and 1147 controls genotyped for GRK5 polymorphisms (rs2230349 and rs2230345).
  • Analysis of genetic variants' effects on GRK5-mediated inflammation in peripheral blood mononuclear cells (PBMCs) and THP-1 macrophages.
  • Evaluation of GRK5's role in a mouse sepsis model (cecal ligation and puncture) using wild-type and GRK5-knockout mice.

Main Results:

  • The GRK5 rs2230349 G>A polymorphism was significantly associated with sepsis subtypes, septic shock, and survival rates.
  • The protective 'A' allele in rs2230349 was linked to lower production of pro-inflammatory cytokines (TNF-α, IL-1β) in PBMCs.
  • In vitro and in vivo studies demonstrated that the Arg-304-His substitution (rs2230349 G>A) in GRK5 reduced inflammatory cytokine production via the IκB-α/NF-κB pathway and improved survival in GRK5-knockout mice.

Conclusions:

  • The rs2230349 G-to-A mutation in GRK5 may confer a protective genetic effect against sepsis progression and mortality.
  • This mutation appears to alleviate inflammatory responses mediated by the IκB-α/NF-κB pathway.
  • Findings may explain clinical prognosis heterogeneity in sepsis and suggest avenues for personalized treatment strategies.